Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET - Gennari, A; Brain, E; De Censi, A (Ann Oncol, 2024)